Ning Zou

USPTO Granted Patents = 17 (Patent Applications = 15)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 7)

Average Co-Inventor Count = 6.8

ph-index = 6

Forward Citations = 92(Granted Patents)

Location History:

San Diego, IN (US) (2015)
West Lafayette, IN (US) (2020)
San Diego, CA (US) (2012 - 2021)

Company Filing History:

16 out of 216

Arena Pharmaceuticals, Inc.

Years Active: 2012-2025

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE50267 - Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto (2025-01-14),

2. 11098034 - Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto (2021-08-24),

3. 10793529 - Substituted pyridazines and 1,2,4-triazines as prostacyclin receptor modulators (2020-10-06),

4. 10689372 - Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto (2020-06-23),

5. 10668033 - Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto (2020-06-02),

6. 10624972 - Conjugates for treating diseases (2020-04-21),

7. 10214518 - Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto (2019-02-26),

8. 10138210 - Substituted pyridazines as prostacyclin receptor modulators (2018-11-27),

9. 9987252 - Primary amines and derivitves thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto (2018-06-05),

10. 9663500 - Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto (2017-05-30),

11. 9328107 - [object Object] (2016-05-03),

12. 9012478 - Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto (2015-04-21),

13. 8940891 - Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto (2015-01-27),

14. RE45336 - Primary amines and derivatives thereof as modulators of the 5-HTserotonin receptor useful for the treatment of disorders related thereto (2015-01-12),

15. 8895776 - Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto (2014-11-25),

Title: Ning Zou: Innovating Treatments for Complex Disorders

Introduction

Ning Zou is a prominent inventor based in San Diego, California, known for his significant contributions to the field of pharmaceuticals. With a total of 16 patents to his name, Zou has made notable advancements in the treatment of various medical conditions, particularly those related to the prostacyclin (PGI2) receptor.

Latest Patents

Among his latest patents, Zou has developed amide derivatives aimed at modulating the activity of the PGI2 receptor. These compounds and their pharmaceutical compositions have been directed toward the treatment of several disorders, including pulmonary arterial hypertension (PAH) and coronary artery disease, among others. His innovative work includes addressing conditions such as myocardial infarction, atherosclerosis, and various diabetic-related disorders through his patented formulations.

In addition, he has designed pyrazole derivatives, which also target the PGI2 receptor. These derivatives have further potential applications in managing conditions like asthma, multiple sclerosis, inflammatory diseases, and chronic obstructive pulmonary disorder (COPD).

Career Highlights

Ning Zou has established his career at Arena Pharmaceuticals, a company that focuses on innovative medicines to improve patient outcomes. His patents not only reflect his expertise in research but also indicate his commitment to developing therapies that tackle complex health issues.

Collaborations

In his work, Ning Zou has collaborated with notable colleagues such as Thuy-Anh Tran and Young-Jun Shin. These collaborations have further enhanced his research impact, driving innovative solutions in the pharmaceutical field.

Conclusion

Ning Zou's inventive spirit and dedication to tackling challenging medical disorders reflect his significant role in advancing pharmaceutical innovations. With a robust portfolio of patents and impactful collaborations, he continues to pave the way for groundbreaking treatments that hold the promise of better health outcomes for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.